Ryosuke Shinouchi
Hatanodai, 1428555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SMTP-44D Improves High Glucose-Induced Vascular Endothelial Dysfunction.
Journal: Biological & pharmaceutical bulletin
Published: January 12, 2026
SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosis.
Journal: Journal of pharmacological sciences
Published: April 18, 2025
Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse model.
Journal: Journal of diabetes and its complications
Published: January 14, 2025
Analysis of oxytocin and oxytocin receptor expressions after hand therapy treatment in a mouse model of chemotherapy-induced peripheral neuropathy .
Journal: Neuro endocrinology letters
Published: January 15, 2024
The effect of hand therapy on alleviating chemotherapy-induced peripheral neuropathy in a model mouse.
Journal: Neuroscience letters
Published: December 18, 2022
SMTP-44D Exerts Antioxidant and Anti-Inflammatory Effects through Its Soluble Epoxide Hydrolase Inhibitory Action in Immortalized Mouse Schwann Cells upon High Glucose Treatment.
Journal: International journal of molecular sciences
Published: March 29, 2022
Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in mice.
Journal: Pharmacology research & perspectives
Published: September 30, 2021
SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activities.
Journal: Pharmacology research & perspectives
Published: June 06, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026